Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Analysis of TIRASMUS data identifies possible marker of temsirolimus efficacy in colorectal cancer

Oct. 21, 2011

Clinical data analyses examine efficacy and safety of lorcaserin

Oct. 20, 2011

Korean scientists identify serum biomarkers of preeclampsia

Oct. 20, 2011

Brazilian university designs new analgesic with in vivo activity

Oct. 20, 2011

Phase II study assessed combination therapy containing rilotumumab in cancer

Oct. 20, 2011

Vandetanib/bicalutamide combination trial does not meet primary endpoint

Oct. 20, 2011

Exparel leads to sustained release of bupivacaine

Oct. 20, 2011

Analyses focus on cardiovascular risk with naltrexone/bupropion

Oct. 19, 2011

U.S. universities assess CDME in model of cystinuria

Oct. 19, 2011

Orantinib advances through studies in NSCLC and breast cancer

Oct. 19, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...